Shortening the second phase duration of biphasic shocks: Effects of class III antiarrhythmic drugs on defibrillation efficacy in humans

Béla Merkely, Andrzej Lubiński, Orsolya Kiss, Ferenc Horkay, Eva Lewicka-Nowak, Maciej Kempa, Zoltán Szabolcs, György Nyikos, Endre Zima, Grazyna Świa̧tecka, László Gellér

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Introduction: The specific waveform providing optimal defibrillation threshold (DFT) is unknown. We compared the defibrillation efficacy of biphasic pulses with second phases (P2) of 2 and 5 msec in a randomized prospective clinical study. Methods and Results: Intraoperative DFTs of 62 patients (age 54 ± 13 years; ejection fraction 43% ± 17%; amiodarone 47%, d,l-sotalol 13%) were determined in random order using a binary search protocol. Anodal shocks of 60% tilt first phases (P1) and P2 of 2 msec/5 msec were delivered from two 100-μF capacitors between the right ventricular electrode and the test housing of a Phylax 06/XM device. Mean DFT was significantly lower using the shorter P2 (9.5 ± 4.5 J vs 11.3 ± 5.2 J; P < 0.0001). According to subgroup analysis, the effect of changing P2 duration was only influenced by antiarrhythmic treatment. DFT decreased markedly using the shorter P2 in patients treated with amiodarone (10.7 ± 4.9 J vs 13.4 ± 5.6 J; P < 0.00001) or d,l-sotalol (6.1 ± 3.3 J vs 9.1 ± 4.6 J; P < 0.05). The difference in patients not treated with Class III drugs was found to be insignificant. Chronic amiodarone treatment increased DFT only when the longer P2 was used. Conclusion: Biphasic shocks with shorter P2 should be used in patients undergoing Class III antiarrhythmic treatment.

Original languageEnglish
Pages (from-to)824-827
Number of pages4
JournalJournal of Cardiovascular Electrophysiology
Volume12
Issue number7
DOIs
Publication statusPublished - Jan 1 2001

Keywords

  • Defibrillation
  • Drugs
  • Shock

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Fingerprint Dive into the research topics of 'Shortening the second phase duration of biphasic shocks: Effects of class III antiarrhythmic drugs on defibrillation efficacy in humans'. Together they form a unique fingerprint.

  • Cite this